IDEAS home Printed from https://ideas.repec.org/a/oup/scippl/v31y2004i5p385-395.html
   My bibliography  Save this article

Trends and gaps in biotechnology policies in European Member States since 1994

Author

Listed:
  • Jacqueline Senker

Abstract

Most European national policy systems have gradually intensified their efforts to support the development of the biotechnology knowledge base and its industrial application. The aim of this paper is to increase understanding of the national approaches to promote biotechnology in Europe, to explore heterogeneity and general trends in the design and implementation of policy instruments, and finally to identify the gaps in national innovation policies since 1994 in Europe. The paper analyses policy intervention in the four main networks of the biotechnology innovation system: the knowledge base; the industry; the financial system; and the market. Copyright , Beech Tree Publishing.

Suggested Citation

  • Jacqueline Senker, 2004. "Trends and gaps in biotechnology policies in European Member States since 1994," Science and Public Policy, Oxford University Press, vol. 31(5), pages 385-395, October.
    • Handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:385-395
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.3152/147154304781779886
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yumiko Okamoto, 2011. "Stem Cells as a Driver of the Knowledge Economy: Progress and Challenges Facing Scotland," SPRU Working Paper Series 189, SPRU - Science Policy Research Unit, University of Sussex Business School.
    2. Hopkins, Michael M. & Crane, Philippa & Nightingale, Paul & Baden-Fuller, Charles, 2019. "Moving from non-interventionism to industrial strategy: The roles of tentative and definitive governance in support of the UK biotech sector," Research Policy, Elsevier, vol. 48(5), pages 1113-1127.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:385-395. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Oxford University Press (email available below). General contact details of provider: https://academic.oup.com/spp .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.